Komori
Governance4578Otsuka Holdings Co.,Ltd.Pharmaceuticals

Notice Regarding the Transition to a Company with an Audit and Supervisory Committee

Subject to approval at the annual general meeting scheduled for March 2027, the Company plans to change from a company with an Audit & Supervisory Board to a company with an Audit and Supervisory Committee. The Nomination and Compensation Committee will remain in place after the transition.

Worth reading
75Important
Scored from 2 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Governance structure

Scheduled transition to a Company with an Audit and Supervisory Committee (currently a Company with a Board of Corporate Auditors)
Committee1
The Nomination and Compensation Committee will remain in place. The proportion of outside committee members is 非開示.
Changes this time

Subject to approval at the annual general meeting scheduled for March 2027, the Company plans to change from a company with an Audit & Supervisory Board to a company with an Audit and Supervisory Committee. The Nomination and Compensation Committee will remain in place after the transition.

Governance structure
ItemDetails
Corporate Governance StructureScheduled transition to a Company with an Audit and Supervisory Committee (currently a Company with a Board of Corporate Auditors)
CommitteeThe Nomination and Compensation Committee will remain in place. The proportion of outside committee members is Not disclosed.
Changes this timeSubject to approval at the annual general meeting scheduled for March 2027, the Company plans to change from a company with an Audit & Supervisory Board to a company with an Audit and Supervisory Committee. The Nomination and Compensation Committee will remain in place after the transition.
Items this document does not state (5)
Number of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The aim is to strengthen the Board of Directors' oversight function, speed up decision-making, enhance the Board's effectiveness, and accelerate efforts to sustainably improve corporate value over the medium to long term.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Transition to a Company with an Audit and Supervisory Committee | Otsuka Holdings Co.,Ltd. (4578) timely disclosure | Komori